Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the ...

(CNN) - The Food and Drug Administration is warning of fake Ozempic that could pose a safety risk. The FDA and Ozempic manufacturer Novo Nordisk have found counterfeit vials of the weight-loss drug ...

The Federal Drug Administration (FDA) warns patients about fake Ozempic, saying it could pose a safety risk. The FDA and ...